XML 55 R42.htm IDEA: XBRL DOCUMENT v3.7.0.1
Collaborative Arrangements and Pending Acquisition - Aggregate VIE Financial Information (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Dec. 31, 2016
Dec. 31, 2015
Jun. 30, 2015
Dec. 31, 2014
Variable Interest Entity, Primary Beneficiary, Does Not Hold Majority Voting Interest, Disclosures [Abstract]            
Provision for income taxes $ (3,985) $ (5,485)        
Net income attributable to noncontrolling interest (1,792) (5,529)        
Variable Interest Entity, Consolidated, Carrying Amount, Assets and Liabilities, Net:            
Restricted cash and cash equivalents (VIE) 44,564   $ 47,762      
Prepaid expenses and other current assets 128,493   70,534      
Intangible assets 284,340   284,340      
Goodwill 50,384   50,384      
Other assets 11,494   11,885      
Accounts payable 63,145   61,451      
Other current liabilities 277,962   315,249      
Deferred tax liability, net 135,402   134,063      
Other liabilities 28,467   28,699      
Noncontrolling interest 182,785   181,609      
BioAxone Biosciences Inc            
Variable Interest Entity, Primary Beneficiary, Does Not Hold Majority Voting Interest, Disclosures [Abstract]            
Contingent consideration, liability 18,900   18,000      
Parion Sciences, Inc            
Variable Interest Entity, Primary Beneficiary, Does Not Hold Majority Voting Interest, Disclosures [Abstract]            
Provision for income taxes (400) (3,100)        
Contingent consideration, liability 241,600   238,800      
Variable Interest Entity, Consolidated, Carrying Amount, Assets and Liabilities, Net:            
Intangible assets         $ 255,300  
Variable Interest Entity, Primary Beneficiary            
Variable Interest Entity, Primary Beneficiary, Does Not Hold Majority Voting Interest, Disclosures [Abstract]            
Loss attributable to noncontrolling interest before provision for income taxes 1,547 839        
Provision for income taxes 391 3,062        
(Increase) decrease in fair value of contingent milestone and royalty payments (3,730) (9,430)        
Net income attributable to noncontrolling interest (1,792) (5,529)        
Variable Interest Entity, Consolidated, Carrying Amount, Assets and Liabilities, Net:            
Restricted cash and cash equivalents (VIE) 44,564   47,762      
Prepaid expenses and other current assets 5,957   6,812      
Intangible assets 284,340   284,340      
Goodwill 19,391   19,391      
Other assets 687   399      
Accounts payable 1,080   415      
Taxes payable 1,159   1,330      
Other current liabilities 1,998   2,137      
Deferred tax liability, net 133,058   131,446      
Other liabilities 300   300      
Noncontrolling interest 182,785   $ 181,609      
Variable Interest Entity, Primary Beneficiary | BioAxone Biosciences Inc            
Variable Interest Entity, Primary Beneficiary, Does Not Hold Majority Voting Interest, Disclosures [Abstract]            
(Increase) decrease in fair value of contingent milestone and royalty payments (900) (430)        
Variable Interest Entity, Consolidated, Carrying Amount, Assets and Liabilities, Net:            
Intangible assets           $ 29,000
Variable Interest Entity, Primary Beneficiary | Parion Sciences, Inc            
Variable Interest Entity, Primary Beneficiary, Does Not Hold Majority Voting Interest, Disclosures [Abstract]            
(Increase) decrease in fair value of contingent milestone and royalty payments $ (2,830) $ (9,000)        
Variable Interest Entity, Consolidated, Carrying Amount, Assets and Liabilities, Net:            
Intangible assets       $ 255,300